Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs.
about
Modulating mitochondrial quality in disease transmission: towards enabling mitochondrial DNA disease carriers to have healthy childrenGenetic manipulation for inherited neurodegenerative diseases: myth or reality?Mitochondrial cytochrome c oxidase deficiencyBarth Syndrome: From Mitochondrial Dysfunctions Associated with Aberrant Production of Reactive Oxygen Species to Pluripotent Stem Cell StudiesA new age in functional genomics using CRISPR/Cas9 in arrayed library screeningThe application of CRISPR-Cas9 genome editing in Caenorhabditis elegansMitochondrial DNA disease-molecular insights and potential routes to a cureEvolutionary defined role of the mitochondrial DNA in fertility, disease and ageingMitochondrial DNA damage induced autophagy, cell death, and diseaseToward a therapy for mitochondrial diseaseMitochondrial DNA disease and developmental implications for reproductive strategiesSmall mitochondrial-targeted RNAs modulate endogenous mitochondrial protein expression in vivo.Controlling gene networks and cell fate with precision-targeted DNA-binding proteins and small-molecule-based genome readers.Comprehensive analysis of the specificity of transcription activator-like effector nucleases.Selective elimination of mitochondrial mutations in the germline by genome editingStochastic modelling, Bayesian inference, and new in vivo measurements elucidate the debated mtDNA bottleneck mechanism.International regulatory landscape and integration of corrective genome editing into in vitro fertilization.Mitochondrial DNA: impacting central and peripheral nervous systems.The use of mitochondria-targeted endonucleases to manipulate mtDNAThe impact of mitochondrial function/dysfunction on IVF and new treatment possibilities for infertility.The role of mitochondrial DNA mutation on neurodegenerative diseases.Mitochondrial Diseases Part I: mouse models of OXPHOS deficiencies caused by defects in respiratory complex subunits or assembly factors.Mitochondrial Diseases Part III: Therapeutic interventions in mouse models of OXPHOS deficiencies.Mitochondrial disease: clinical aspects, molecular mechanisms, translational science, and clinical frontiers.Near-complete elimination of mutant mtDNA by iterative or dynamic dose-controlled treatment with mtZFNs.Seamless editing of the chloroplast genome in plants.Mitochondrial Respiratory Defect Causes Dysfunctional Lactate Turnover via AMP-activated Protein Kinase Activation in Human-induced Pluripotent Stem Cell-derived Hepatocytes.Modifying the Mitochondrial Genome.Emerging therapies for mitochondrial disorders.Mitochondria in pluripotent stem cells: stemness regulators and disease targets.A Phenotype-Driven Approach to Generate Mouse Models with Pathogenic mtDNA Mutations Causing Mitochondrial Disease.Mitochondrial Transfer by Photothermal Nanoblade Restores Metabolite Profile in Mammalian Cells.Evolution of Cell-to-Cell Variability in Stochastic, Controlled, Heteroplasmic mtDNA Populations.Selective removal of deletion-bearing mitochondrial DNA in heteroplasmic Drosophila.Gene Therapy for Leber Hereditary Optic Neuropathy: Initial Results.The Development of TALE Nucleases for Biotechnology.Development of pharmacological strategies for mitochondrial disorders.Expert consensus document: Mitochondrial function as a therapeutic target in heart failureMitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations.Mitochondrial Modification Techniques and Ethical Issues.
P2860
Q26741333-91722B51-D25F-4E7C-9E60-7077CE580F8AQ26752831-CE6ACFE1-170C-44F5-AC13-FF82D9438883Q26769015-F149667E-BD08-40DF-89CA-7D6DB2DD58E8Q26772690-6163B642-922C-4175-B38F-2CA3D1BD3BC4Q26781135-55066822-8C5B-48A2-99F7-A3D7ED83D01BQ26785937-BF0016AB-C3FE-48A0-90EA-BED7812F76BEQ27005350-8F126357-C453-4565-947A-B961042C7308Q27024089-F0DA8233-7E9B-4989-87B9-7C64182B0176Q28072518-02296186-6526-4D18-8A9D-0B01F8154891Q28080024-05BF5454-79F0-41E3-89BA-DCFE2778C5ACQ28649392-26E8EA4C-DBF9-4BF1-821F-6CB37E30E4E5Q33931594-DA8DE1F6-5D43-4836-A6E4-C6EF29BD4EE1Q34381076-D9155B90-BC94-4CD6-8F42-A46DD7D044A6Q34406749-AD3F996A-96F7-474F-A752-BDDF34E40400Q34473537-B2553D77-5DB3-4296-920F-E98F054251FDQ34478955-A7D6B82D-7F9F-4646-A099-DF209961C9DAQ34611496-93F55681-1EAB-4081-B506-984383F3AA49Q34737643-278D470C-636D-4778-A996-57C1850C2F6EQ34758002-44CB9540-3E7F-4F71-B8AE-C573C4284BD5Q34979054-5B0EB4FB-27C8-455D-AFC5-FA0FF3FFFDD8Q35152954-5636B537-6124-4781-8E82-0F8BD864985CQ35190973-526D7DB3-FE6E-4EEA-BD78-3FDD243C3F69Q35893619-E012F972-EE21-48BC-A309-8F5AC78727C3Q35997215-5D1A8D71-8526-4EE9-9849-49DBD0F39B4DQ36088172-B560D00F-7DBB-4EA9-9F44-FFA62F357F96Q36090529-478F3E2E-6F11-4A8F-948B-1E667D6A4E12Q36444101-6337EA46-05C5-458D-AF85-595D83E11812Q36894373-56561FCC-A26B-4F95-B677-F38A4D8D7C76Q36967723-2AB3D18F-8751-4F05-8828-82C740421B87Q37232271-6F02D0F6-3B41-4AAC-A386-A1ED0C7ABEF8Q37289982-A7EEA279-BACB-4AF1-9552-8BF51749920AQ37336497-AC9B50B1-F815-490E-A363-B94A4729A8E8Q37396906-C4EC1CF2-C945-413D-913C-62F49EB1960CQ37421594-B2B9930F-7AFB-4309-83E0-59DA944A0766Q37618929-6BDADCAC-75DE-4D4D-843C-19AB75CC87F2Q37652116-AF3C8065-6EF3-41FE-8E18-2CDEB86641C0Q37686237-609F0294-22E6-4DBF-856D-76E30252EFE1Q37699474-4C975193-A12F-4BB5-8ADB-C0F33A7D3BD5Q37710809-51D680F1-34D8-4467-85ED-D8CFBF1DB45EQ37729935-9059CD34-4B36-40A3-9E10-128A6B74C3D1
P2860
Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Specific elimination of mutant ...... t-derived cells by mitoTALENs.
@ast
Specific elimination of mutant ...... t-derived cells by mitoTALENs.
@en
Specific elimination of mutant ...... t-derived cells by mitoTALENs.
@nl
type
label
Specific elimination of mutant ...... t-derived cells by mitoTALENs.
@ast
Specific elimination of mutant ...... t-derived cells by mitoTALENs.
@en
Specific elimination of mutant ...... t-derived cells by mitoTALENs.
@nl
prefLabel
Specific elimination of mutant ...... t-derived cells by mitoTALENs.
@ast
Specific elimination of mutant ...... t-derived cells by mitoTALENs.
@en
Specific elimination of mutant ...... t-derived cells by mitoTALENs.
@nl
P2093
P2860
P356
P1433
P1476
Specific elimination of mutant ...... t-derived cells by mitoTALENs.
@en
P2093
Carlos T Moraes
Milena Pinto
Sandra R Bacman
Siôn L Williams
Susana Peralta
P2860
P2888
P304
P356
10.1038/NM.3261
P407
P577
2013-08-04T00:00:00Z
P5875
P6179
1029698832